期刊文献+

两种药物性肝病诊断标准的对比研究 被引量:8

Comparison of two diagnostic criteria for drug-induced liver disease
下载PDF
导出
摘要 目的比较药物性肝病(DILD)通用诊断标准及Maria评分系统,探讨DILD分级量化诊断的可行性及应用价值。方法分别以通用诊断标准及Maria评分对325例疑诊为DILD的病例进行回顾性诊断及评分,比较评分分值在符合与不符合通用诊断标准的两组之间的分布情况,研究分值与定性诊断之间的关系。结果325例患者中218例符合通用诊断标准,其中208例(95.4%)计分≥10分,107例不符合通用诊断标准,其中79例(73.8%)计分<10分。经ROC分析,Maria标准曲线下面积为0.9121,95%置信区间为(0.8803,0.9439)(Z=25.40,P<0.001)。Maria评分≥10分诊断DILD的敏感性为95.4%,特异性为73.8%。结论两种DILD诊断标准具有较好的一致性,Maria评分系统诊断DILD敏感性高,但特异性较低。 [Objective] To compare Maria clinical scale for the diagnosis of drug-induced liver disease (DILD) with the current criterion and investigate the validation and the value of this scale. [Methods] The information of 325 suspected cases of DILD was scored by Maria scale and diagnosed by current criterion, The relation between the distribution of scores and the diagnosis of these cases was studied and analyzed. [ Results ] There were 218 cases conformed to the criterion, and 208 of them (95.41%)were scored ≥10. There were 107 cases that were not coincident with criterion, and 79 of them were scored 〈10. The area under ROC curve of Maria scale was 0.9121. The 95% confidence interval was (0.8803,0.9439) (Z =25.40,P 〈0.001). The sensitivity and specificity of Maria score≥10 for diagnosing DILD were 95.41%and 73.83%. [Conclusions] The Maria clinical scale for diagnosing DILD is in correspondence with current criterion. The Maria scale shows good sensitivity and little low specificity and should be improved on basis of actual situation of China.
作者 于涛 文卓夫
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第17期2157-2159,共3页 China Journal of Modern Medicine
关键词 药物性肝病 诊断 drug-induced liver disease diagnosis
  • 相关文献

参考文献9

  • 1LEWIS JH.Drug-Induced Liver Disease[J].Med Clin North Am,2000,84(5):1275-1311. 被引量:1
  • 2GUO CJ.Drug-induced jaundice.In:ZHENG ZT.Gastroenterology[M].3rd ed.Beijing:People's Medical Publishing House,2000,1026-1029.Chinese 被引量:1
  • 3MARIA VA,VICTORINO RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[J].Hepatology,1997,26(3):664-669. 被引量:1
  • 4WANG JY,GUO JS.Diagnosis and treatment of drug-induced liver disease[J].Chinese Journal of Hepatology,2004,12(4):242.Chinese 被引量:1
  • 5SHEN YD.Present condition and prospect of research in thalassemia in Guangdong[J].Guangdong Medical Journal,1998,19(4):243-244.Chinese 被引量:1
  • 6RUSSO MW,WATKINS PB.Are patients with elevated liver tests at increased risk of drug-induced liver injury[J].Gastroenterology,2004,126(5):1477-1480. 被引量:1
  • 7BONACINI M.Liver injury during highly active antiretroviral therapy:the effect of hepatitis C coinfection[J].Ciln Infect Dis,2004,38(suppl 2):S104-S108. 被引量:1
  • 8刘斌,朱小寒,彭红军.抗结核药物所致肝病的影响因素[J].中国现代医学杂志,2005,15(9):1407-1409. 被引量:2
  • 9DE ABAJO FJ,MONTERO D,MADURGA M,et al.Acute and clinically relevant drug-induced liver injury:a population based case-control study[J].Br J Clin Pharmacol,2004,58(1):71-80. 被引量:1

二级参考文献7

共引文献1

同被引文献97

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部